Stratview Research delivers key insights on the global Anti-Depressant Market. According to Stratview Research, the market is segmented By Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist, Reuptake Inhibitors, Others), End-User (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Others), and Region.
The report also covers the Covid impact on the market. Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and an uptrend is witnessed from 2021.
Get a free sample report here: https://www.stratviewresearch.com/Request-Sample/2418/Anti-Depressant-Market.html#form
Market Insights
The report suggests that the overall Anti-Depressant market is projected to grow from USD 14.3 billion in 2020 to USD 17.5 billion by 2026 at a CAGR of around 3.4% during the forecast period.
Market Segments' Analysis
By depressive disorder, the anti-depressant market has been bifurcated into major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others. Under these, the major depressive disorder segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be an increasing number of people suffering from depression.
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The regional growth is primarily attributed to the high prevalence of depression, expanding geriatric populace, and presence of key market players such as Bristol Myers Squibb (US) and Eli Lilly and Company (US). The market growth in the Asia-Pacific region is expected to be driven by rising awareness among consumers regarding depression disease in developing countries, particularly China and India.
Key Players
The following are some of the key players in the Anti-Depressant Market:
· Alkermes (Ireland)
· Allergan, Inc. (Ireland)
· Bristol Myers Squibb (US)
· Eli Lilly and Company (US)
· GlaxoSmithKline plc (UK)
· H. Lundbeck A/S (Denmark)
· The Merck Group (Germany)
· Pfizer Inc. (US)
· Teva Pharmaceutical Industries Ltd. (Israel)
· The Takeda Pharmaceutical Company Limited (Japan)
FREQUENTLY ASKED QUESTIONS
The report answers several questions related to the market. The user can get to know the answers to the following questions…
- What is the global demand for Anti-Depressant Market in terms of revenue?
- Which are the prominent players in the market?
- At what CAGR is the market projected to grow within the forecast period?
- What are the driving factors fuelling the growth of the market?
- Which region accounted for the largest share in the market?
- How did the Covid19 impacted the market?
- How long will it take to recover from the Covid impact?
Why Stratview Research?
- Exhaustive qualitative and quantitative data
- Uninterrupted post-sales support
- Appropriate market trend and forecast analysis.
- All-inclusive report
- Decent price-performance ratio
- Reliable data
- Attractive market segments and associated growth opportunities.
- Customised report services
About Us –
Stratview Research is a leading global market research firm providing expert research solutions, trusted by clients worldwide. To keep our clients ahead of the curve, we provide data backed by extensive market research and in-depth industry knowledge. The broad spectrum of integrated insights is referred to, and cited by press releases, interview with key players, white papers, journals, etc. Stratview research also offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please connect with our team.
Get in touch with us for more details –
Call: +1-313-307-4176 Or Mail Us: sales@stratviewresearch.com
Write a comment